IP Library Granted Patent US 9,976,119
Granted Patent B2
US 9,976,119 · App. 15/157,201 · Granted May 22, 2018

Compositions and methods for improving the quality of processed sperm

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,976,119
App. No.
15/157,201
Granted
May 22, 2018
Kind
B2
Abstract

The present invention relates to compositions and methods for the handling of processed sperm including samples that are freshly collected, those transported as fresh samples, samples that are frozen and thawed, those sorted into one or more subpopulations, and those that are otherwise processed or handled that impose trauma on the cell. Trauma can reduce the motility, fertility, viability and overall integrity of the sperm and reduce the ability to fertilize, produce an embryo and a healthy offspring. The present invention relates to novel compounds that can be added to the sperm cell sample to reduce the traumatic effects of physical stress during mild as well as extensive sperm cell processing, methods of using the compounds in standard sperm processing procedures, the end products made from these methods including sperm and embryos, as well as methods of using those end products in assisted reproductive biology techniques in animals.

Claims (20)

1. A method of fertilizing one or more eggs, comprising the steps of:

providing a sperm cell sample in a media making a sperm cell composition, wherein the media comprises vitamin B12, or a vitamin B12 vitamer, at a concentration of about 0.01 mg/ml to 1 mg/ml and alpha-ketoglutarate; and

contacting the one or more eggs with one or more sperm cells from the sperm cell composition.

2. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is selected from the group consisting of: 0.01 to 0.25 mg/ml; 0.01 to 0.5 mg/ml; 0.05 to 0.1 mg/ml; 0.05 to 1.0 mg/ml; 0.1 to 0.25 mg/ml; 0.1 to 0.5 mg/ml; 0.1 to 1 mg/ml; 0.15 to 0.45 mg/ml; 0.15 to 0.5 mg/ml; 0.25 to 0.35 mg/ml; 0.25 to 0.5 mg/ml; 0.25 to 1 mg/ml; 0.35 to 0.5 mg/ml; 0.35 to 1 mg/ml; and 0.5 to 1 mg/ml.

3. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is selected from the group consisting of: about 0.05 mg/ml; about 0.1 mg/ml; about 0.15 mg/ml; about 0.25 mg/ml; about 0.35 mg/ml; about 0.45 mg/ml; and about 0.5 mg/ml.

4. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.15 mg/ml, about 0.25 mg/ml or about 0.35 mg/ml.

5. The method of claim 1 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.25 mg/ml.

6. The method of claim 1 , wherein the concentration of the alpha-ketoglutarate in the media is about 0.15 mg/ml to 0.5 mg/ml.

7. The method of claim 1 , wherein the sperm cell sample has been sex-sorted.

8. The method of claim 1 , wherein the sperm cell sample has been processed by ablating unwanted cells.

9. The method of claim 1 , further comprising the step of freezing and thawing the sperm cell sample or the sperm cell composition.

10. The method of claim 1 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee or gorilla, or a whale, dolphin or other marine mammal.

11. A method of fertilizing one or more eggs, comprising the steps of:

providing a sex-sorted sperm cell sample, or a sperm cell sample processed by ablating unwanted cells, in a media making a sperm cell composition, wherein the media comprises vitamin B12, or a vitamin B12 vitamer, at a concentration of about 0.01 mg/ml to 1 mg/ml; and

contacting the one or more eggs with one or more sperm cells from the sperm cell composition.

12. The method of claim 11 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.15 mg/ml, about 0.25 mg/ml or about 0.35 mg/ml.

13. The method of claim 11 , wherein the concentration of the vitamin B12, or the vitamin B12 vitamer, in the media is about 0.25 mg/ml.

14. The method of claim 11 , wherein the media further comprises alpha-ketoglutarate.

15. The method of claim 11 , further comprising the step of freezing and thawing the sperm cell sample or the sperm cell composition.

16. The method of claim 11 , wherein the sperm cell sample is derived from a human, bovine, swine, ovine, equine, deer, elk, buffalo, canine, feline, chimpanzee or gorilla, or a whale, dolphin or other marine mammal.

Assignments (3)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
SECURITY INTEREST Recorded Mar 31, 2021
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2016
From: LENZ, RICHARD; MORENO, JUAN; VISHWANATH, RAMAKRISHNAN
To: INGURAN, LLC
Reel/Frame 038659/0699 →